BlackRock’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338K | Buy |
319,295
+18,609
| +6% | +$19.7K | ﹤0.01% | 4461 |
|
|
2025
Q1 | $409K | Sell |
300,686
-735
| -0.2% | -$1K | ﹤0.01% | 4402 |
|
|
2024
Q4 | $416K | Buy |
301,421
+245
| +0.1% | +$338 | ﹤0.01% | 4403 |
|
|
2024
Q3 | $322K | Buy |
301,176
+1,473
| +0.5% | +$1.58K | ﹤0.01% | 4376 |
|
|
2024
Q2 | $644K | Buy |
299,703
+8,617
| +3% | +$18.5K | ﹤0.01% | 4229 |
|
|
2024
Q1 | $946K | Sell |
291,086
-14,755
| -5% | -$48K | ﹤0.01% | 4152 |
|
|
2023
Q4 | $6.27M | Buy |
305,841
+263,679
| +625% | +$5.4M | ﹤0.01% | 3529 |
|
|
2023
Q3 | $678K | Buy |
42,162
+18,680
| +80% | +$300K | ﹤0.01% | 4274 |
|
|
2023
Q2 | $200K | Sell |
23,482
-459,947
| -95% | -$3.91M | ﹤0.01% | 4649 |
|
|
2023
Q1 | $4.77M | Buy |
483,429
+38,220
| +9% | +$377K | ﹤0.01% | 3575 |
|
|
2022
Q4 | $4.24M | Buy |
445,209
+256,924
| +136% | +$2.45M | ﹤0.01% | 3730 |
|
|
2022
Q3 | $3.27M | Buy |
188,285
+1,175
| +0.6% | +$20.4K | ﹤0.01% | 3863 |
|
|
2022
Q2 | $1.45M | Buy |
+187,110
| New | +$1.45M | ﹤0.01% | 4298 |
|